Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects with an IPAA (PROF)
- First Posted Date
- 2023-07-10
- Last Posted Date
- 2025-02-24
- Lead Sponsor
- Exegi Pharma, LLC
- Target Recruit Count
- 50
- Registration Number
- NCT05938465
- Locations
- 🇺🇸
Cedars-Sinai Medical Center, Los Angeles, California, United States
🇺🇸Mayo Clinic - Florida (Inflammatory Bowel Disease Center), Jacksonville, Florida, United States
🇺🇸Corewell Health, Grand Rapids, Michigan, United States
News
No news found